Arioneo, a French company which specializes in the development and marketing of analysis solutions for the performance and health of equine athletes, has created a new study aimed at the deployment of a new generation of automated ECG-analysis algorithms capable of detecting cardiac rhythm abnormalities, including atrial fibrillation (AFib), across training, racing and resting conditions. In a press release Tuesday, the company states that the study is "powered by an artificial intelligence engine trained on one of the largest exercise ECG datasets in the racing industry, [which] enables, for the...